Sputnik Lite: Russia develops single dose vaccine, effective against all variants of Corona

Moscow, Ta. May 6, 2021, Thursday

The Covid-19 epidemic is spreading in India day by day. Russia, on the other hand, has shocked the world by developing a single dose of corona. Russia has approved the use of the Sing dose vaccine 'Sputnik Light'. This information was given by the health officials of Russia. Financial assistance has been provided by RDIF (Direct Investment Fund) for the manufacture of vaccines.

The Sputnik Light has performed well, RDIF said in a statement. The single dose of Sputnik Lite is 79.4 per cent effective against the two-dose Sputnik-V Corona which is 91.6 per cent successful. Sputnik light will speed up vaccinations and help prevent the spread of coronary heart disease. The RDIF said that a single dose of Sputnik Lite costs less than 73 10, or Rs 737.

Kiril Dimitriev, chief executive officer of RDIF, claimed that the Sputnik light vaccine would reduce the number of critically ill patients admitted to the hospital. Not only that, it has also been shown to be effective against all variants of the corona virus.

This light version of Sputnik-Vini has also been prepared by the Gamaleya Research Institute in Moscow. Russia's two-dose Sputnik-V has so far been approved by 60 countries, including India. A quantity of vaccine has reached India.